BIO Statement on Confirmation of Ms. Seema Verma

March 13, 2017

BIO congratulates Ms. Seema Verma on her successful confirmation to lead the Centers for Medicare and Medicaid Services (CMS). We look forward to working with her and Secretary Price to advance patient-centric policies that promote affordable access to medicines and continued innovation.

Discover More

BIO Statement on Most Favored Nation

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…

Learn more

BIO Statement on Industry Tariffs

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…

Learn more

BIO Extends Agreement with Avantor for Five…

Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…

Learn more